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A large subset of mammalian imprinted genes show extra-embryonic lineage (EXEL) speciﬁc imprinted
expression that is restricted to placental trophectoderm lineages and to visceral yolk sac endoderm (ysE).
Isolated ysE provides a homogenous in vivomodel of a mid-gestation extra-embryonic tissue to examine
the mechanism of EXEL-speciﬁc imprinted gene silencing, but an in vitro model of ysE to facilitate more
rapid and cost-effective experiments is not available. Reports indicate that ES cells differentiated into
cystic embryoid bodies (EBs) contain ysE, so here we investigate if cystic EBs model ysE imprinted
expression. The imprinted expression pattern of cystic EBs is shown to resemble fetal liver and not ysE.
To investigate the reason for this we characterized the methylome and transcriptome of cystic EBs in
comparison to fetal liver and ysE, by whole genome bisulphite sequencing and RNA-seq. Cystic EBs show
a fetal liver pattern of global hypermethylation and low expression of repeats, while ysE shows global
hypomethylation and high expression of IAPEz retroviral repeats, as reported for placenta. Transcriptome
analysis conﬁrmed that cystic EBs are more similar to fetal liver than ysE and express markers of early
embryonic endoderm. Genome-wide analysis shows that ysE shares epigenetic and repeat expression
features with placenta. Contrary to previous reports, we show that cystic EBs do not contain ysE, but are
more similar to the embryonic endoderm of fetal liver. This explains why cystic EBs reproduce the
imprinted expression seen in the embryo but not that seen in the ysE.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
Genomic imprinting is an epigenetic phenomenon that leads to
parental allele-speciﬁc or imprinted expression of approximately
150 mouse genes, more than 80% of which are grouped intor Inc. This is an open access article
ski),
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Biophysics, PAS, 02-106 War-clusters. Gamete-speciﬁc DNA methylation of an imprint control
element (ICE) controls imprinted expression of the entire cluster,
as has been demonstrated by genetic deletion in seven cases
(Barlow and Bartolomei, 2014). In the most common mechanism
of imprinted silencing, the unmethylated ICE allele is associated
with the promoter of a long non-coding (lnc) RNA that initiates
silencing of imprinted genes in the cluster, as has been demon-
strated for four of the seven clusters (Mancini-Dinardo et al., 2006;
Meng et al., 2012; Sleutels et al., 2002; Williamson et al., 2011).
While most imprinted genes show some degree of tissue-speciﬁc
regulation of imprinted expression (Prickett and Oakey, 2012), two
broad types have been identiﬁed: multi-lineage (ML) and extra-
embryonic lineage (EXEL) speciﬁc imprinted expression. ML
imprinted expression is seen in both embryonic and extra-
embryonic tissues. EXEL imprinted expression is restricted to
placental trophectoderm lineages and the visceral yolk sac (VYS)
endoderm layer (ysE) (Hudson et al., 2011). In imprinted clusters,under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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located further away from the ICE and the lncRNA that silences
them, presenting a model of long-range cis silencing by lncRNAs
(Kulinski et al., 2013).
Extra-embryonic tissues show a chromatin state distinct from
embryonic lineages, for example displaying global DNA hypo-
methylation (Chapman et al., 1984; Popp et al., 2010; Rossant et al.,
1986). EXEL imprinted expression has been suggested to arise
from a more permissive chromatin organization in extra-
embryonic tissues that allows the silencing mechanism to extend
over greater distances (Hudson et al., 2010; Kulinski et al., 2013),
or from repression of EXEL speciﬁc enhancers by imprinted
lncRNAs (Pauler et al., 2012). Testing these hypotheses in vivo
require laborious genetic experiments to manipulate the imprin-
ted cluster in the endogenous locus in the mouse. In comparison,
genetic studies in ex vivo model systems are faster and more cost
effective. Research on the mechanism of ML imprinted expression
has been facilitated by the use of an ex vivo model system
employing ES cell differentiation (Kohama et al., 2012; Latos et al.,
2009; Meng et al., 2012; Wood et al., 2010). The ysE, which arises
from the primitive endoderm of the pre-implantation embryo,
forms the external layer of the bilaminar VYS that encloses the
embryo after the embryo turns around E8.5 and remains until
birth. Although stem cells known as XEN cells that model the
primitive endoderm have been derived and display some markers
of visceral endoderm, they are largely unable to contribute to the
visceral endoderm in chimeras (Kunath et al., 2005). In contrast, ES
cells differentiated in vitro by aggregation into small non-attached
cell clumps called embryoid bodies (EBs) eventually develop cystic
structures that closely resemble the bilaminar structure of the VYS
and have been considered to contain ysE (Abe et al., 1996;
Doetschman et al., 1985; Kurosawa, 2007; Yasuda et al., 2009).
Electron microscopy studies also showed the outer epithelial layer
of cystic EBs contained microvilli and cytoplasmic vacuoles similar
to the ysE (Doetschman et al., 1985). Further support that differ-
entiating ES cells into cystic EBs provides an ex vivo model of ysE
development comes from studies showing that the outer endo-
dermal-like layer expresses visceral endoderm markers such as Afp
and Ttr, as well as endoderm-speciﬁc transcription factors such as
Hnf1, vHnf1, Hnf3b, Hnf4 and Gata4 (Abe et al., 1996; Doetschman
et al., 1985; Koike et al., 2007; Kurosawa, 2007; Sajini et al., 2012;
Sakai et al., 2011; Soudais et al., 1995). Despite this, the ability of
cystic EBs to model EXEL imprinted expression of the ysE has not
yet been tested.
Here we developed a robust protocol to differentiate mouse ES
cells into cystic EBs and determined if this ex vivo system can be
used as a model of ysE imprinted expression. We show that many
ysE EXEL imprinted genes were either not expressed, or very lowly
expressed in cystic EBs. Furthermore, while cystic EBs robustly
displayed the ML type of imprinted expression, all EXEL genes
expressed above baseline levels exhibited biallelic expression.
Using whole genome bisulphite converted DNA sequencing
(WGBS) we showed that cystic EBs exhibit a high level of DNA
methylation comparable to that observed in fetal liver, and not the
lower levels observed in ysE. Using RNA-seq transcriptome and
WGBS analysis, we further showed that cystic EBs, rather than
resembling ysE, are more closer related to the deﬁnitive endoderm
derived fetal liver. Finally, we comprehensively annotated the ysE
transcriptome and identiﬁed a characteristic set of genes that are
absent from the cystic EB transcriptome. Together these results
indicate that cystic EBs have an embryonic-like epigenetic state,
contain embryonic endoderm rather than extra-embryonic endo-
derm, and, while a useful resource for analyzing ML imprinted
expression in different tissue-types, they cannot be used as a
model for EXEL imprinted expression.Material and methods
Tissue collection and VYS layers separation
Mice were bred and housed at the IMBA/IMP facility in Vienna
in strict accordance with national recommendations under
Laboratory Animal Facility Permit MA58-0375/2007/4. Fetal liver,
VYS and VYS endoderm (ysE) were collected from E12.5 FVB/N or
CAST/EiJ FVB/N F1 crosses. Separated ysE and mesoderm was
collected from E9.25 FVB/N embryos. In each case the entire litter
was pooled for each sample. The VYS endoderm and mesoderm
layers were manually separated using a DispaseII pre-treatment
for 1 h (E9.5) and 2 h (E12.5) as described (Hudson et al., 2011).
The VYS mesoderm was collected together with the vasculature
and the basement membrane, while the ysE was collected alone.
The accuracy of separation was assessed using RT-qPCR for mar-
kers of ysE (Afp) and mesoderm (Flk1).
ES cell lines
Mouse ES cell lines were derived from CAST/EiJ FVB/N crosses
(described below, clones CF-C2 (XY) and FC-A2 (XY) were used), or
from C57BL/6129 crosses (clone A9 (XY) from Anton Wutz,
clone JN (XX) from Jennifer Nichols). ES cells were maintained in
DMEM based medium with 15% fetal calf serum and LIF, on irra-
diated E12.5 mouse embryonic ﬁbroblast feeders according to
standard protocols. ES cells were differentiated in retinoic acid
(RA) as described previously (Latos et al., 2009) or into cystic EBs
as described below. The A9 and JN cells showed a normal kar-
yotype and the CF-C2 and FC-A2 clones showed normal differ-
ential methylation of tested ICE as described below. All ES cell lines
also showed normal ES cell morphology and growth dynamics.
Derivation of ES cells from CAST FVB F1 crosses
ES cells were derived from reciprocal crosses of CAST/EiJ FVB/N
using a method adapted from a published protocol (Bryja et al.,
2006). In brief, harvested blastocysts were incubated in Tyrodes acid
for 30–60 s till the zona pellucida dissolved. Afterwards, blastocysts
were plated onto MEF feeder layers in SR-ES medium (Table S2) and
left undisturbed for two days to allow attachment. Medium was
changed every two days. After 6 days the blastocysts hatched and
were trypsinized (0.25% trypsin–EDTA) for the ﬁrst time and plated
onto a new well of MEF-feeders in ES medium (Table S2). After one
additional week ES cells were growing out and the best looking
colonies were sub-cloned and mechanically passaged. Between
3 and 8 ES cells sub-clones were picked per blastocyst (5 CAST FVB
blastocysts, 3 FVBCAST blastocysts, maternal allele on the left).
Each clone was sex-typed, checked for differential methylation of the
Dlk, Igf2r and Kcnq1 cluster ICE, and the general morphology and
growth characteristics were noted.
A robust protocol for cystic EB differentiation
To produce comparable EB populations we started differentia-
tions from ES cells between 18 and 21 passages. Previously mul-
tiple protocols for ES cell differentiation into cystic EBs have been
proposed. However, most of them depend on a random or poorly
controlled aggregation of ES cells and thus are hampered by poor
reproducibility of the starting aggregate size (Kurosawa, 2007).
The starting cell number in the initiating clumps in suspension
cultures has been shown to determine the simple EB versus cystic
EB composition of the differentiated populations and substantially
inﬂuence endoderm marker expression (Koike et al., 2007; Yasuda
et al., 2009). To increase the reproducibility of ES cell differentia-
tion to cystic EBs and lineage choice we used AggreWell™400
Fig. 1. Cystic embryoid bodies (EBs) express a subset of endoderm markers and have a membrane-like morphology. (A) The protocol used to differentiate ES cells into cystic
EBs. (B) Left: light microscope image of cystic EBs (scale bar: 1 mm) differentiated for 10 (d10) and 15 (d15) days. Middle: the relative abundance of cystic and solid EBs at d10
and d15. Right: the diameter of cystic EBs at d10 and d15. (C) Histological section of d15 cystic EBs stained with haematoxylin and eosin showing their characteristic
organization with a solid node of cells localized to one end and an outer bi-laminar layer containing columnar epithelium (scale bar top: 500 mm, bottom: 50 mm). (D) RT-PCR
shows that general endoderm markers (black font) and speciﬁc anterior and deﬁnitive endoderm markers (gray font) are robustly detected in cystic EBs, but the latter
markers are not found in E12.5 visceral yolk sac endoderm (ysE) or visceral yolk sac (VYS) (ES d0: undifferentiated ES cells). (E) RT-PCR shows that four extra-embryonic
lineage (EXEL) speciﬁc imprinted genes are either lowly expressed (Slc22a3, Ins2) or not detectable after 40 PCR cycles in d10/d15 cystic EBs, whereas they are robustly
expressed in ysE and VYS. With the exception of Tfpi2, ES d0 cells also do not express the EXEL genes tested. (F) Control actin RT-PCR. (G) Whole mount in situ hybridization
(WISH) detects the expression of endoderm markers Afp and Ttr in cystic EBs (scale: 1 mm). (H) Histological sections of WISH stained cystic EBs localize Afp and Ttr
expression to the outer columnar epithelium layer (scale left: 100 mm, right: 50 mm).
T.M. Kulinski et al. / Developmental Biology 402 (2015) 291–305 293plates to control the aggregate starting size (Stemcell Technologies
#05893) as previously described (Fig. 1A) (Antonchuk, 2013). We
optimized the protocol to maximize the proportion of cystic EBs
and determined that starting aggregates of 1000–2000 ES cells
yielded consistent cystic morphology (Fig. 1B). Therefore weproceeded with the analysis of cystic EBs initiated with an average
starting aggregate of 1000 cells (1.2106 cells suspended in 2 ml
media centrifuged into 1200 microwells). After 8 h incubation in
AggreWell™ plates in LIFþES cell media to allow the cells to
attach to each other, the aggregates were ﬂushed out with a
T.M. Kulinski et al. / Developmental Biology 402 (2015) 291–305294stream of media from a pipette and transferred to non-adhesive
dishes (Corning Ultra Low Attachment 75 cm2 ﬂasks) and cultured
in 25–30 ml media as ﬂoating cultures in ES cell medium without
LIF (25 ml media in early stages, 30 ml media from d10). By day
5 of differentiation, EBs were still very homogenous in shape and
size with many showing the ﬁrst signs of cavitation by developing
hollow buds. After day 5, those buds developed and underwent a
phase of extensive growth between day 7 and 10 to eventually
form cystic EBs. By day 10 and 15 of differentiation approximately
90% of the aggregates represented cystic EBs with an average size
of 1.05 mm and 1.32 mm, respectively (Fig. 1B). These structures
could be sustained in culture for at least 2 months, but their
morphology and size did not signiﬁcantly change beyond day 20.
An outer layer of columnar epithelial cells surrounded the solid
EBs whereas cystic EBs usually had a pole resembling the solid EB
and an additional cystic part consisting of a large membrane-like
structure that had mostly a double cell layer (Fig. 1C). The outer
layer of cystic EBs appeared to show an epithelial morphology
whereas the inner lining resembled mesothelial cells (Fig. 1C).
Between those two layers empty spaces were sometimes seen that
may represent blood islands. In combination these features
resemble the yolk sac histology as reported before (Fig. S1A)
(Wang et al., 1992; Zhou et al., 2005). Using this protocol we were
also able to differentiate cystic EBs from the classical 129/SvPas
(D3) and 129/SvEv (CCE) inbred ES cell lines, which showed a
similar morphology and expression of markers to the F1 ES cells.
Taken together these results show that the EB differentiation
protocol that we applied, allows robust generation of a relatively
pure population of cystic EBs reproducing the previously reported
morphology (Abe et al., 1996; Doetschman et al., 1985; Kurosawa,
2007; Niwa, 2010; Yasuda et al., 2009).
Histology and whole mount in situ hybridizations (WISH)
To assess cystic EB histology, cystic EBs differentiated for 10
(d10) and 15 (d15) days were ﬁxed for 10 min in 4% paraf-
ormaldehyde, cryopreserved in 30% sucrose in PBS overnight at
4 °C, and snap-frozen in OCT and cryosectioned using CryoJanes
Tape-Transfer System. Subsequent haematoxylin–eosin staining
was performed according to standard protocol. Probe sequences
for WISH were PCR ampliﬁed (primers in Table S3), cloned into
pGEM-Ts easy vector and then PCR ampliﬁed using M13 primers.
This puriﬁed PCR product was then used as a template for T7 or
SP6 polymerase in vitro transcription to produce antisense and
sense riboprobes depending on the template orientation in the
vector. Signal detection was performed using Afp, Ttr, Lefty and Pyy
probes according to a published protocol (Piette et al., 2008).
Cystic EBs d15 were pierced to avoid probe trapping. WISH sam-
ples were cryosectioned as above and counterstained with Con-
trastReds and photographed using a stereoscopic microscope.
DNA and RNA analysis
Total RNA and DNA were extracted using TRI-reagent (Sigma-
Aldrich T9424) according to the manufacturers protocol. Total RNA
was DNase1 treated using the DNA-free™ kit (Ambion). Reverse
transcription (RT) was performed using the Revert Aid First Strand
cDNA Synthesis Kit (Fermentas) with random hexamer primers.
cDNA was ampliﬁed according to standard procedures using the
GoTaqs Flexi DNA polymerase (Promega) or the Long PCR Mix
enzyme (Fermentas). Primers are listed in Supplementary mate-
rials (Table S3). PCR amplicons were resolved on standard agarose
gel and puriﬁed using Wizards SV Gel Clean-Up System and
subject to Sanger sequencing. For genes showing a reciprocal bias
the allelic contribution was quantiﬁed from the sequencing chro-
matograms using Mutation Surveyors software.RNA-seq, ChIP-seq, and whole genome bisulﬁte sequencing (WGBS)
Ribosomal RNA was depleted from total DNaseI-treated RNA
using the RiboZero rRNA removal kit (Human/Mouse/Rat) (Epi-
center). Three different methods of RNA-seq libraries preparation
were used (detailed in Table S4): (1) non-stranded RNA-seq from
double-stranded cDNA (Huang et al., 2011), (2) strand-speciﬁc
RNA-seq libraries prepared using ScripSeq v1 kit (Epicenter), and
(3) TruSeq RNA Sample Prep Kit v2 (Illumina) modiﬁed by using
dUTP instead of dTTP during second-strand cDNA synthesis, fol-
lowed by subsequent uracil-DNA glycosylase (UDG) (Fermentas)
degradation of the second strand after adapter ligation to preserve
strand information as described (Sultan et al., 2012). Native ChIP
for H3K4me3 (antibody: cat. 07-473, lot 0608038479, Millipore)
was conducted by homogenizing 20 VYS under liquid nitrogen
(E12.5 FVB/N pooled from 2 litters) and then proceeding as pre-
viously described (Regha et al., 2007). ChIP-seq libraries were
prepared using TruSeq ChIP Sample Prep Kit (Illumina). Libraries
for whole genome bisulphite sequencing (WGBS) were prepared
using the TruSeq DNA LT Sample Prep Kit v2 (Illumina) with a
conversion step before the library ampliﬁcation using the EZ DNA
Methylation-DirectTM Kit reagents according to the protocol
(except the bisulﬁte reaction mix was diluted 0.9 ), with 20
cycles of 1 min at 95 °C then 10 min at 60 °C. The incubation time
for desulphonation was extended to 30 min. All sequencing was
performed by the Biomedical Sequencing Facility (BSF) in Vienna
using the Illumina HiSeq 2000 platform (detailed in Table S4).
Bioinformatic analysis
The RNA-seq, ChIP-seq and WGBS data was aligned using
GSNAP aligner and further processed and analyzed as described
below. Custom scripts, Samtools (version 0.1.16) and RSeQC (ver-
sion 2.3.3) were used to generate RPKM tables, read count tables,
and UCSC tracks for visualization. FastQC was used to assess
sequence read quality (Quinlan and Hall, 2010; Wu and Nacu,
2010). Cufﬂinks (version 2.1.1) was used to de novo annotate
transcripts in the RNA-seq data. To reduce artefacts the de novo
Cufﬂinks annotations were ﬁltered for spliced transcripts with a
minimum length of 500 nt using custom scripts in R programing
language (http://www.r-project.org), incorporating Bedtools
(v2.17.0). Custom scripts incorporating Bedtools were also used for
feature overlap analysis between the de novo transcripts and
DESeq and DEXSeq BioConductor packages were used to call dif-
ferentially expressed transcripts and differential exon usage
respectively. Gene ontology analysis was done using DAVID online
tools (Huang et al., 2009). ChIP-seq data was analyzed using MACS
(version 1.4.2) and SeqMonc (http://www.bioinformatics.babra
ham.ac.uk/projects/seqmonk/) (Anders and Huber, 2010; Huang
et al., 2009; Quinlan and Hall, 2010; Trapnell et al., 2010; Zhang
et al., 2008). Graphs displaying the result of bioinformatic analysis
were constructed in R programing language (http://www.r-pro
ject.org). Supervised hierarchical clustering of E9.25 ysE, E12.5 ysE,
cystic EBs and E12.5 fetal liver samples was done by the expression
of selected developmental markers using Pearson’s correlation as a
measure of clustering distances and the “complete” agglomeration
method for dendogram generation (Fig. 4D). Unsupervised classi-
ﬁcation of E9.25 ysE, E12.5 ysE, cystic EBs and E12.5 fetal liver
samples was done according to 3133 RefSeq protein coding genes
that showed a highly signiﬁcant (Po103) difference in expres-
sion between E12.5 fetal liver and E12.5 ysE (Fig. S4E) using the
“complete” agglomeration method for dendrogram generation
(Fig. 4E). CpG methylation in the WGBS reads was called using the
BisSNP package using low coverage settings (Liu et al., 2012) and a
FVB/Cast SNP list (Keane et al., 2011; Wong et al., 2012). Custom
scripts incorporating Bedtools were used to prepare the count
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tering of tissues by DNA methylation in Fig. 3B was done using
5 kb non-overlapping windows that showed the greatest similarity
between replicates (n¼4996), but differed with at least one other
tissue. Windows were selected that had an interquartile range
(IQR) o10% within tissue replicates, but IQR 420% between tis-
sues. Euclidian distances and the “complete” agglomeration
method was used for dendrogram generation. All custom scripts
are available on request. High throughput sequencing data has
been deposited in NCBI's Gene Expression Omnibus (GEO) data-
base under the accession number GSE56276 (http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc¼GSE56276) (Table S4).Results
Cystic EBs express endoderm markers but lack expression of some
EXEL imprinted genes
We developed a protocol to differentiate ES cells into a rela-
tively pure population of cystic EBs (approximately 90% of EBs
after 10 or 15 days of differentiation) that reproduced the pre-
viously published cystic morphology more robustly (Fig. 1A–C)
(Doetschman et al., 1985; Kurosawa, 2007; Niwa, 2010; Yasuda
et al., 2009). Cystic EBs were reported to express endoderm mar-
kers in their outer epithelial layer (Abe et al., 1996; Koike et al.,
2007; Yasuda et al., 2009). We were able to conﬁrm expression of
endoderm markers in our cystic EBs by RT-PCR, including Afp and
Ttr as well as the Gata4 and Hnf4α transcription factors that are
required for endoderm development (Fig. 1D). As positive controls
we used isolated ysE dissected free of the mesodermal layer and
blood islands (Hudson et al., 2011) and intact VYS from E12.5
embryos. We also conﬁrmed that Afp and Ttr expression is loca-
lized to the external epithelial cell layer of cystic EBs by in situ
hybridizations for these genes (Figs. 1G–H and S1B,C). RT-PCR
detected expression of Amn and Sox7 in cystic EBs and in ysE and
VYS (Fig. 1D). Both genes are expressed in the primitive endoderm
derived visceral endoderm (VE). However, by E7.5 Sox7 localizes
mainly to the extra-embryonic part of VE that overlays the extra-
embryonic ectoderm and later develops into ysE (Kanai-Azuma
et al., 2002), Amn localizes to both the extra-embryonic VE and the
embryonic VE that overlays the epiblast and later contributes to
embryonic endoderm (Kalantry et al., 2001; Kwon et al., 2008).
Later in development Sox7 is also expressed in developing gut,
pancreas, liver and lung, and during embryonic angiogenesis and
in heart (Lioubinski et al., 2003; Matsui et al., 2006; Takash et al.,
2001), whereas Amn plays an essential role for intestine and kid-
ney proximal tubules development and is expressed in those tis-
sues (Strope et al., 2004). Therefore, these genes are not speciﬁc
markers for extra-embryonic VE and ysE. The expression of Sox17
was clearly detected in cystic EBs but not in ysE (Fig. 1D). Based on
the known expression pattern of Sox17, this indicates that cystic
EBs either contain an earlier developmental stage of VE prior to
VYS formation or contain deﬁnitive endoderm (Kanai-Azuma
et al., 2002). We also examined Lefty1 and Mixl1 that are markers
of embryonic VE and deﬁnitive endoderm, although Mixl1 is also
expressed in other lineages including mesoderm (Pearce and
Evans, 1999). Lefty1 was detected in cystic EBs and undiffer-
entiated ES cells but not in ysE (Figs. 1D and S1D). Mixl1 was
expressed in cystic EBs but was also detected in ysE (Fig. 1D). Pyy,
which has been reported to have its expression restricted to
foregut deﬁnitive endoderm derivatives (Hou et al., 2007), was
detected in cystic EBs but not in ysE (Figs. 1D and S1E). We then
tested the expression of four EXEL imprinted genes (Fig. 1E). All
were robustly expressed in ysE and VYS samples, but only after 40
cycles of PCR was low level expression of Ins2 and Slc22a3 detectedin cystic EBs, while Slc22a2 and Tfpi2 were not detected. Tfpi2 was
strongly expressed in undifferentiated ES cells prior to down
regulation upon differentiation in EBs. We also examined marker
expression by PCR at day 5 of differentiation prior to cystic EB
formation when EBs were still very homogenous in shape and size
but many were beginning to show the ﬁrst signs of cavitation with
developing hollow buds. Afp, Ttr and Slc22a3 were already detec-
ted at this early stage, but the speciﬁc ysE marker Slc22a2 was not
detected (Fig. S1F). In summary, cystic EBs express markers of
endoderm in their outer epithelial layer as reported before, but the
expression pattern of a limited set of markers indicates a deﬁnitive
endoderm rather than an extra embryonic ysE identity. Further-
more, cystic EBs fail to express, or show very low expression, of
some EXEL imprinted genes that are typically highly expressed in
the ysE.
Cystic EBs show ML imprinted expression
We next assessed the ability of cystic EBs to model imprinted
expression. We used RT-PCR followed by Sanger sequencing of cystic
EBs differentiated from two F1 ES cell lines with a FVB/CAST and the
reciprocal CAST/FVB genetic background, plus E12.5 ysE and fetal
liver from the same crosses (Fig. 2A, B). We ﬁrst examined allelic
expression of a selection of ML imprinted genes that belong to
clusters that also contain EXEL imprinted genes expressed in cystic
EBs. All tested ML genes showed the expected maternal (Igf2r,
Cdkn1), or paternal (Airn, Kcnq1ot1, Peg10), imprinted expression
pattern in cystic EBs and in the extra-embryonic (ysE) and embryonic
(fetal liver) endoderm controls (Fig. 2C). Igf2 only showed a paternal
expression bias (30% maternal and 70% paternal) in cystic EBs
(Fig. S2A). The incomplete imprinted silencing of Igf2 may be
explained by the presence of early haematopoiesis in cystic EBs
(Dang et al., 2002; Doetschman et al., 1985) as human hematopoietic
cells relax Igf2 imprinted expression (Hofmann et al., 2002). Together
these results demonstrated that imprinted expression is regulated
normally in cystic EBs. Thus cystic EBs are a useful developmental
model of ML imprinted expression.
Cystic EBs do not reproduce the EXEL imprinted expression of yolk sac
endoderm
The lack of expression of some ysE EXEL imprinted genes in
cystic EBs (Fig. 1D), demonstrated that cystic EBs could not be used
to model EXEL-speciﬁc imprinted expression for these genes. To
investigate the utility of cystic EBs in general to model EXEL
imprinted expression we examined imprinted expression of ysE
EXEL genes that were expressed in cystic EBs. The EXEL imprinted
genes Osbpl5, Cd81, Tssc4, Sfmbt2 and Ppp1r9a showed biallelic
expression in cystic EBs similar to that observed in fetal liver,
while the ysE showed imprinted expression (or strong maternal
bias in the case of Tssc4). Sfmbt2 showed a strain bias towards the
FVB allele in cystic EBs and fetal liver although there was clear
imprinted expression in ysE (Fig. 2D), so we conﬁrmed the biallelic
expression of Sfmbt2 in cystic EBs derived from two independent
B6/129 F1 ES cell lines (Fig. S2B). The reported ysE EXEL gene Pon2
could not be tested in the CAST/FVB system due to a strong strain
bias, but it also showed biallelic expression in cystic EBs derived
from the two B6/129 F1 ES cell lines (Fig. S2B). In contrast to other
EXEL imprinted genes, the lowly expressed Slc22a3 demonstrated
a reciprocal maternal biased expression of approximately 66%
maternal to 34% paternal in d10 cystic EBs and 70% maternal to
30% paternal in d15 cystic EBs, while the control ysE showed 100%
maternal expression (Figs. 2D and S2C). At d5 the low level of
Slc22a3 detected showed biallelic expression further indicating
that no ysE is present at this early stage of cystic EB differentiation
(Fig. S2D). ES cells differentiated in a monolayer with retinoic acid
Fig. 2. Cystic EBs show multi-lineage (ML) but not extra-embryonic lineage (EXEL) speciﬁc imprinted gene expression. (A) The breeding scheme used to obtain reciprocal
crosses between the FVB/N (FVB) and CAST/EiJ (CAST) mouse strains for imprinted expression analysis using single nucleotide polymorphisms (SNPs). (B) Embryos at E6.5
and E12.5 indicating embryonic and extra-embryonic tissues (VYS diagram adapted from Hudson et al. (2011)). (C) The ML imprinted genes Igf2r, Cdkn1c (maternally-
expressed), and Kcnq1ot1, Airn, Peg10 (paternally-expressed) that represent 3 out of 4 imprinted clusters that contain EXEL genes, show the expected reciprocal imprinted
expression pattern in cystic EBs, E12.5 yolk sac endoderm (ysE) and E12.5 fetal liver. The expressed SNP is shown above each Sanger sequencing chromatogram, FVB and
CAST alleles are indicated on the right. (D) The EXEL genes Osbpl5, Cd81, Tssc4, and Ppp1r9a from the Kcnq1 and Peg10 imprinted clusters show biallelic expression in cystic
EBs. The solo EXEL gene Sfmbt2 shows a strain bias between FVB and CAST so biallelic expression in cystic EBs was validated in B6/129 ES cells (Fig. S2B). The Slc22a3 EXEL
gene from the Igf2r cluster shows a reciprocal bias in cystic EBs with very low expression requiring 40 PCR cycles and multiple reactions to acquire enough DNA for
sequencing. Each EXEL gene shows imprinted expression in E12.5 ysE and biallelic expression in E12.5 fetal liver. SNPs are displayed above the chromatograms with a single
base indicating robust imprinted expression, both SNP bases indicating biallelic expression, and both SNP bases with one in bolded font indicating biased expression. The
maternal allele is written on the left.
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similar low level of Slc22a3 expression and maternal bias to d10
and d15 cystic EBs, indicating that at least in cell culture, Slc22a3Fig. 3. Cystic EBs lack epigenetic features of visceral yolk sac endoderm. (A) Global DNA
shows greater similarity with the DNA methylation level of E12.5 fetal liver. Whole geno
genome. Box plots show the range of DNA methylation for each tissue indicating the med
liver than E12.5 ysE by DNA methylation levels. Hierarchical clustering was done using 5
differed with at least one other tissue (details in Supplementary materials). (C) De novo
kilobase per million reads (RPKM)) in RNA-seq data from cystic EBs than in E9.5, 12.5 ys
DNA methylation in E12.5 ysE compared to d15 cystic EBs, which show levels more simi
with E12.5 ysE showing a lower level of DNA methylation than d15 cystic EBs, which sho
of methylation for each sample indicting the median and IQR. (E) E12.5 ysE expresses IAP
no difference in expression. The Kernel density plot displays the probability of repeats
expression, negative values represent overexpression in E12.5 ysE, positive values re
chromatin modifying complexes from RNA-seq data. (G) No difference in the global le
H3K27ac, H3K27me3, H3K9me3 and H3K9me2 histone modiﬁcations in undifferentiate
antibody is provided below each of the modiﬁcations as a loading control. Error bar
***Pr0.001).may show maternal biased expression not restricted to EXEL tis-
sues (Fig. S2E). Together these results show that cystic EBs do not
display the EXEL imprinted expression pattern typical of ysE, butmethylation in E12.5 yolk sac endoderm (ysE) is lower than in d15 cystic EBs, which
me bisulﬁte sequencing (WGBS) data was analyzed using 5 kb windows across the
ian and the interquartile range (IQR). (B) Cystic EBs (d15) cluster closer to E12.5 fetal
kb windows (n¼4996) that showed the greatest similarity between replicates, but
DNA methyltransferases Dnmt3b and Dnmt3l are more highly expressed (reads per
E and fetal liver. (D) IAPEz repeats are highly methylated, but show a lower level of
lar to E12.5 fetal liver. LINE repeats are less methylated, but show a similar pattern
w levels more similar to fetal liver. Box plots (shaded as in 3A) show the percentage
ez repeats at a higher level than cystic EBs, while SINEs, LINEs, and all repeats show
showing different expression in these two tissues (x-axis: log2 fold difference in
present overexpression in cystic EBs). (F) The expression of selected genes from
vel of histone modiﬁcations was detected by Western blot analysis for H3K4me3,
d ES cells, cystic EBs d15, E12.5 ysE, E12.5 total VYS and E12.5 fetal liver. A pan-H3
s in (C) and (F) show the standard error of the mean (*Pr0.05, **Pr0.01, and
T.M. Kulinski et al. / Developmental Biology 402 (2015) 291–305298instead show an imprinted expression pattern resembling that
seen in embryonic lineages.
Cystic EBs lack the epigenetic hallmarks of yolk sac endoderm
Cystic EBs lack EXEL imprinted expression, a characteristic epi-
genetic feature of ysE. Therefore, we investigated cystic EBs for other
epigenetic features that are known to distinguish the extra-
embryonic ysE from embryonic lineages. The extra-embryonic
lineages have been shown to be hypomethylated on speciﬁc repeti-
tive elements and genic sequences (Chapman et al., 1984; Rossant
et al., 1986) and placenta globally shows low DNA methylation (Popp
et al., 2010). To determine the DNAmethylation state in cystic EBs we
performedWGBS on d15 cystic EBs and compared it to E12.5 ysE and
fetal liver. Fig. 3A shows that genome-wide ysE has relatively low
levels of DNA methylation (median 53.3–62.5%) compared to fetal
liver (median 79–79.6%) consistent with previous ﬁndings compar-
ing the extra-embryonic placenta and embryonic tissues (Popp et al.,
2010). However, DNA methylation in cystic EBs does not resemble
ysE, but displays a slightly higher level than fetal liver (median 85.3–
89.9%). Moreover by hierarchical clustering the global methylation
pattern of cystic EBs was closer to fetal liver than to ysE (Fig. 3B).
A similar picture was observed when tissues were clustered by
the methylation of repeats, promoters or CpG islands (Fig. S3A–C).
Analysis of RNA-seq data showed that the maintenance DNA
methyltransferase Dnmt1 was expressed at a high level in all tissues,
while the de novo methyltransferase Dnmt3a was expressed at a
more moderate level in all tissues (Fig. 3C). The de novo methyl-
transferases Dnmt3b and Dnmt3L were expressed more highly in
cystic EBs compared to E12.5 and E9.5 ysE and E12.5 liver. This may
explain why a slightly higher level of global DNA methylation was
seen in cystic EBs compared to fetal liver. However, analysis of the
pluripotency markers Oct4 and Rex1 showed that although they are
strongly down regulated during cystic EB differentiation, they are
still expressed, raising the possibility that remnant pluripotent cells
may exist in cystic EBs (Fig. S1G). This could explain the expression of
Dnmt3l in cystic EBs, as it showed a similar pattern of expression to
the pluripotency markers during cystic EB differentiation, but could
not explain the expression pattern of Dnmt3b, which was expressed
at a higher level than the pluripotency markers (Fig. S1H). High
Dnmt3b expression has been previously reported in EBs (Leitch et al.,
2013), and may be explained by the presence of early embryonic
ectoderm cells in EBs, which express a high level of Dnmt3b in the
early post-implantation embryo (Okano et al., 1999).
We next evaluated levels of methylation on CpG islands (Fig. S3D),
genic elements (Fig. S3E), and different types of repeats (Figs. 3D and
S3F,G). As expected the bulk of CpG islands were unmethylated
(median o10%) in contrast to the rest of the genome, which was
highly methylated in fetal liver and cystic EBs (median 79–89.5%),
and showed intermediate levels in ysE (median 53.3–62.5%)
(Fig. S3D). Promoters showed a lower level of DNA methylation than
other genic elements, which was expected due to the overlap of
many CpG islands with promoters (Fig. S3E), and was also consistent
with previous reports (Lister et al., 2009; Popp et al., 2010). Protein-
coding exons, introns and UTRs displayed a similar level of methy-
lation within a tissue type, showing a high level for fetal liver and
cystic EBs (480%) and a more moderate level for ysE (median 65.8–
73.7%, Fig. S3E). Repeats were highly methylated in cystic EBs
and fetal liver, but generally less methylated in ysE (median 50–70%)
(Fig. S3F). This patternwas similar for the SINE, LTR, satellite and DNA
repeat families (Fig. S3G). The intracisternal A particle (IAP) IAPEz
family of retrotransposons showed a higher level of DNAmethylation
than other repeats, although ysE still showed a lower level of
methylation than cystic EBs and fetal liver. In contrast, LINEs were
less methylated than other repeats in ysE (median 30–50%), but not
in cystic EBs and fetal liver (Fig. 3D). It has previously been shownthat IAPEz repeats are highly expressed in the extra-embryonic pla-
centa, but not in embryonic tissues (Reichmann et al., 2013). Analysis
of RNA-seq data showed that ysE express IAPEz repeats highly
compared to cystic EBs (Fig. 3E) and fetal liver (Fig. S3H). SINEs, LINEs
and all repeats grouped together showed no difference in expression
between the tissues. IAPEz expression in cystic EBs, fetal liver and
VYS mesoderm was similar (Fig. S3I, J). Thus ysE shows high
expression of IAPEz like placenta, while cystic EBs show low IAPEz
expression similar to epiblast-derived lineages. LINEs are not
expressed in ysE despite low levels of DNA methylation. In hypo-
methylated primordial germ cells genome defense genes repress the
expression of retrotransposable elements. Similarly, in placenta LINEs
are lowly methylation and are suppressed by the genome defense
gene TEX19.1, which has been reported to show expression restricted
to germ cells and the extra-embryonic placenta (Reichmann et al.,
2013). Tex19.1 is highly expressed in E12.5 ysE and moderately
expressed in E9.5 ysE and cystic EBs, but not expressed in E12.5 liver
(Fig. 3F). This indicates that expression of hypomethylated LINEs in
ysE may be suppressed by TEX19.1, as occurs in placenta, although
the expression levels indicate that this may be more important in late
rather than early ysE.
The repressive histone modifying complex PRC2, which
deposits H3K27me3, plays a role in maintaining imprinted silen-
cing of some genes speciﬁcally in the placenta or its precursor
tissue (Mager et al., 2003; Terranova et al., 2008). EHMT2, which
deposits H3K9me2, may play a role speciﬁcally in EXEL imprinted
silencing of genes in the placenta (Nagano et al., 2008; Wagschal
et al., 2008). Additionally, early embryonic lethality of the Eed
(PRC2) hypomorph been shown to be due to a defect in placenta
development (Wang et al., 2002) indicating an essential role for
H3K27me3 in placenta. Despite this, the H3K27me3 modiﬁcation
deposited by PRC2 is globally low in TS cells and XEN stem cells
that represent the pre-implantation trophectoderm and primitive
endodermwhich generates the trophectoderm of the placenta and
the ysE of the VYS (Rugg-Gunn et al., 2010). Given these reports we
investigated expression of components of histone modifying
complexes in ysE, fetal liver and cystic EBs by RNA-seq. We found
that the PRC2 component Ezh2 showed signiﬁcantly higher
expression in fetal liver and cystic EBs compared to ysE, while
other PRC2 components Suz12, Eed, and Ezh1 showed no sig-
niﬁcant difference between the tissues (Fig. 3F). Other components
of histone modifying complexes Rnf2, Mll1, Ash1, and Ehmt1 also
showed no signiﬁcant differences between the tissues. Ehmt2 did
show higher expression in E12.5 and E9.5 ysE than fetal liver and
cystic EBs, but this difference was not statistically signiﬁcant. Since
signiﬁcant expression differences between ysE and cystic EBs were
seen for the histone modifying enzyme Ezh2, we examined total
levels of the histone modiﬁcations H3K27me3, H3K4me3,
H3K27ac, H3K9me2 and H3K9me3 in ysE, fetal liver and cystic EBs
and compared them to undifferentiated ES cells and VYS by
Western blotting (Fig. 3G). No difference in the total levels of these
modiﬁcations was detected between these tissues. Although it has
been shown that extra-embryonic stem cells in the pre-implan-
tation embryo show a low level of H3K27me3 (Rugg-Gunn et al.,
2010), our result is consistent with immunocytochemistry data
indicating that post-implantation extra-embryonic lineages gain
H3K27me3 (Rugg-Gunn et al., 2010), and indicates that cystic EBs
represent a post-implantation tissue. As an additional marker of
chromatin regulation, we examined expression of the enhancer
associated CBP/p300 interacting protein CITED1, that is expressed
in extra-embryonic VE and later in ysE (Dunwoodie et al., 1998),
and is required for placental development (Rodriguez et al., 2004).
Expression comparison by RNA-seq showed that Cited1 expression
in ysE was signiﬁcantly higher than in cystic EBs and fetal liver
(Fig. 3F). Taken together these results demonstrate that in addition
to failing to display EXEL imprinted expression, cystic EBs do not
T.M. Kulinski et al. / Developmental Biology 402 (2015) 291–305 299possess epigenetic features of ysE such as DNA hypomethylation,
elevated expression of IAPEz retroviral repeats, the Tex19.1 genome
defense gene, and the Cited1 gene. Additionally, high expression
levels of chromatin modifying enzyme Ezh2 in cystic EBs more
resemble the embryonic fetal liver, than the extra-embryonic ysE.Fig. 4. Transcriptome analysis shows that cystic EBs resemble fetal liver more than yolk
yolk sac endoderm (ysE) and cystic EBs shows a weak correlation (left: r2¼0.74), more
liver (middle: r2¼0.70), than to closely related E12.5 and E9.25 yolk sac endoderm (righ
expression of selected developmental markers shows a high similarity in expression patt
pattern of cystic EBs clusters closer to the expression pattern of E12.5 liver. (E) Unsuperv
(Po103) difference in expression between E12.5 fetal liver and E12.5 ysE (Fig. S4E), sho
(D) and (E) detailed in Supplementary materials.The gene expression pattern of cystic EBs is distinct from the yolk sac
endoderm
The expression of some gene markers, the imprinted expres-
sion pattern and epigenetic features indicate that cystic EBs aresac endoderm. (A–C) Scatter plots comparing mean RPKM values from RNA-seq of
similar to distantly related tissues such as E12.5 yolk sac endoderm and E12.5 fetal
t: r2¼0.90). r is the Pearson coefﬁcient of correlation. (D) Supervised clustering by
erns of ysE from two developmental stages (E12.5 and E9.25), while the expression
ised classiﬁcation by all RefSeq protein coding genes that show a highly signiﬁcant
wed that cystic EBs cluster closer to fetal liver than to ysE. Hierarchical clustering for
T.M. Kulinski et al. / Developmental Biology 402 (2015) 291–305300distinct from the yolk sac endoderm and may represent a devel-
opmental stage more similar to the embryonic deﬁnitive endo-
derm. Although RT-PCR of marker genes indicates that cystic EBs
have a deﬁnitive endoderm identity (Fig. 1D), assigning tissue
identity based on a limited set of markers is dependent on
proper selection and could be misleading. Moreover, expression of
some individual markers may be altered in culture. For example,
in vivo Afp is expressed in the embryonic, but not the extra-
embryonic VE, whereas in culture both express Afp (Dziadek,
1978). Therefore, conﬁdent and unbiased classiﬁcation of tissue
identity requires whole transcriptome analysis. To enable this we
performed RNA-seq of cystic EBs at d10 and d15 of differentiation
and compared them to E9.25 and E12.5 ysE and E12.5 fetal liver
(Fig. 4). The mean expression level of biological replicates of cystic
EBs from two independently derived B6/129 ES cells at the d10
and d15 time points showed a high correlation level of r¼0.99,
r2¼0.98 (Fig. S4A) with no signiﬁcantly differentially expressed
genes (Fig. S4C). Therefore, we treated all 4 cystic EB datasets as
biological replicates in comparisons to ysE and fetal liver samples.
The comparison between cystic EBs and E12.5 ysE showed a cor-
relation of r2¼0.74 (Fig. 4A). This correlation resembles that seen
between distantly related tissues, such as E12.5 ysE and fetal liver
(r2¼0.70) (Fig. 4B), rather than the correlation between two clo-
sely related tissues like E9.25 and E12.5 ysE (r2¼0.90) (Fig. 4C). To
classify the type of endoderm contained in cystic EBs, we per-
formed a supervised hierarchical cluster analysis of RNA-seq data
from cystic EBs, ysE and fetal liver using a set of markers reported
to distinguish different types of endoderm and different stages of
ES cell differentiation (Bielinska et al., 1999; Cho et al., 2012).
Samples from each tissue type clustered together, with cystic EBs
clustering closer to fetal liver than ysE, while E9.25 and E12.5 ysE
clustered close to each other (Fig. 4D). Principal component ana-
lysis showed that most variation was explained by tissue differ-
ences and that batch effects only had a minor effect on the hier-
archical clustering of samples (Fig. S4D). Similar to fetal liver,
cystic EBs expressed markers of visceral endoderm (Cited1, Dab2,
Atp6v0a1, Elf1, Ttr, Afp and Apoc2) to a lower level than observed in
E9.25 and E12.5 ysE. Cystic EBs also expressed markers of
embryonic VE and deﬁnitive endoderm (Foxg1a, Gata3, Sp6, Pyy,
Cer1, Gsc, and Lefty1) (Fig. 4D), as was indicated by RT-PCR using a
more limited panel of markers (Fig. 1D). Notably, cystic EBs also
expressed genes associated with early endoderm development
(Gata6, Sox7 and Sox17), parietal endoderm (Fst, Snai1, Pth1r,
Pdgfra, Lamb1-1 and Sparc) and pluripotency-associated genes
(Nanog, Pou5f1, Sox2, Utf1, Zfp42, Eras, Dppa5, Dnmt3l, Col18a1,
Nodal and Gli2) (Fig. 4D). This may indicate that they represent an
earlier stage of development than the ysE and fetal liver samples.
The pluripotency associated genes Oct4 and Rex1 are strongly
down regulated during cystic EB differentiation (Fig. S1G), but
with our analysis it cannot be distinguished if the expression of
pluripotency markers at this level is characteristic of cystic EBs or
due to a sub-population of undifferentiated cells. To further clas-
sify the endoderm of EBs in an unbiased transcriptome-wide way,
we performed hierarchical clustering using genes that most
strongly distinguish E12.5 ysE and fetal liver (3133 genes showing
Po103) (Fig. S4E). The resulting dendrogram showed a similar
picture with samples clustering by tissue type, and cystic EBs
clustering closer to fetal liver than ysE (Fig. 4E). In agreement with
this, a direct comparison of expression patterns between cystic EBs
and fetal liver showed a higher correlation (r2¼0.79) than a direct
comparison between cystic EBs and ysE (r2¼0.74) (Figs. 4A and
S4B). Together these results show that the expression proﬁle of
cystic EBs is more similar to fetal liver than ysE, indicating that the
endoderm contained in cystic EBs resembles more embryonic
deﬁnitive endoderm than extra-embryonic ysE.Cystic EBs have a different regulatory network than the yolk sac
endoderm
Analysis of the imprinted expression pattern, epigenetic proﬁle
and transcriptome of cystic EBs indicates that they contain endo-
derm that is distinct from the ysE. In order to identify the genes and
pathways that are responsible for this difference we performed a
differential expression analysis comparing cystic EBs with ysE.
Using the DESeq BioConductor package we identiﬁed 3674 RefSeq
transcripts differentially expressed between E12.5 ysE and cystic
EBs (FDRo1%) (Fig. S5A). Gene ontology (GO) analysis of deregu-
lated genes using DAVID software showed a signiﬁcant (EASE index
o103, Po103) overrepresentation of transcription factors
(GO:0003700), sequence-speciﬁc DNA binding (GO:0043565) and
growth factors (GO:0008083) indicating that the two tissues have a
different regulatory network (Fig. 5A). To identify genes that are
most likely to be essential for ysE development, and also genes
expressed in cystic EBs that may be antagonistic to ysE develop-
ment, we ﬁltered for those genes that are signiﬁcantly (FDRo5%)
differentially expressed between both ysE stages and cystic EBs,
and are also signiﬁcantly different between E12.5 ysE and fetal liver
(Fig. S5E). This identiﬁed 274 genes that distinguish ysE E9.5 and
E12.5 from cystic EBs and fetal liver, 156 differentially expressed
higher in ysE, and 118 differentially expressed higher in cystic EBs
(Fig. 5B, Table S1). These 156 genes that distinguish ysE from cystic
EBs included the known ysE markers Afp, Apoa2, Amn, Hnf4a and
Apoc2. After this ﬁltering step both the ysE and cystic EB gene sets
still include a number of transcription factors and members of
chromatin modifying complexes that may be involved in regulating
tissue identity (Table S1).
Alternative splicing may result in isoforms that encode differ-
ent protein products or that are differentially regulated by miR-
NAs, and has been suggested to affect differentiation and lineage
commitment (Revil et al., 2010; Salomonis et al., 2010; Trapnell
et al., 2010). Therefore, we compared ysE and cystic EBs to identify
isoform differences that may contribute to their different cellular
identity. A total of 8027 exons contained within 4192 Ensemble
genes showed signiﬁcant (FDRo5%) differential usage between
ysE and cystic EBs (Fig. S5B). To further study the complexity of
splicing in the different tissues and identify novel transcripts, we
performed de novo transcriptome assembly using Cufﬂinks
(Trapnell et al., 2010). To reduce artefacts we ﬁltered for spliced
transcripts with a minimum length of 500 bp leading to the
identiﬁcation of 13,288 loci (containing 45,638 transcripts) in
E12.5 ysE, 14,360 loci (containing 52,555 transcripts) in cystic
EBs and 13,878 loci (containing 55,903 transcripts) in fetal liver
(Fig. S5C). We observed an 85% overlap between the putative
transcription start sites (5'ends) of de novo annotated ysE tran-
scripts and H3K4me3 ChIP-seq peaks from E12.5 VYS (containing
ysE and VYS mesoderm) indicating that our de novo assembly
approach was valid (Fig. S5D). The de novo assemblies included
479 loci in ysE, 289 loci in fetal liver and 216 loci in cystic EB that
have not been previously annotated in publicly available gene or
EST databases (Fig. S5C). From the putative novel ysE loci, 198 out
of 479 were not identiﬁed in cystic EBs. Consistent with the
DEXSeq analysis of Ensembl genes (Fig. S5B), many de novo
assembled loci showed different isoforms usage between ysE and
cystic EBs. This is illustrated by the example of two genes known
to play a role in endoderm development. HNF4A is a transcription
factor involved in regulating the transcriptional program in diverse
endoderm tissues. It is signiﬁcantly differentially expressed, nearly
20 fold higher in E12.5 ysE compared to cystic EBs, while there is
no signiﬁcant expression difference between cystic EBs and E12.5
liver (Fig. 5B, Table S1). Additionally, de novo assembly and dif-
ferential exon usage analysis indicated that while the canonical
Hnf4a isoform was present in ysE, cystic EBs had a longer form
Fig. 5. Cystic EBs have a different regulatory network than the yolk sac endoderm. (A) Pie chart representation of gene ontology (GO) analysis of differentially expressed
genes between E12.5 ysE and cystic EBs. Signiﬁcantly differentially expressed genes detected with a FDR of 1% were analyzed using DAVID (Huang et al., 2009). Over
represented GO groups/terms (based on an EASE score o103) are listed. (B) Genes that show signiﬁcant differential expression between both developmental stages of ysE
(E9.25 and E12.5) and cystic EBs and E12.5 liver are plotted (272 genes, FDRo5%, Fig. S5E). To indicate the direction of differential expression, genes expressed higher in
E12.5 ysE are displayed as positive (156 genes) and higher in cystic EBs as negative (118 genes) log2 P values (Table S1). Members of chromatin modifying complexes and
transcription factors are highlighted in red. Transcripts that were previously published as markers of ysE are marked with an asterisk. (C) E12.5 ysE expresses the RefSeq
annotated shorter isoform of the endoderm speciﬁc regulator Hnf4a, while cystic EBs use an alternative promoter to express a longer form that includes a new ﬁrst exon. Top:
UCSC genome browser screenshot showing the RNA-seq tracks and de novo annotation using Cufﬂinks in cystic EBs and E12.5 ysE (black). Bottom: DEXSeq differential exon
usage analysis shows signiﬁcant differential ﬁrst exon usage. (D) A novel isoform of the Prdm14 transcription factor distinguishes cystic EBs and E12.5 ysE. Top: A UCSC
genome browser screenshot showing RNA-seq for cystic EBs and E12.5 ysE, Cufﬂinks de novo annotation for both tissues (black), H3K4me3 ChIP-seq for E12.5 VYS (gray,
input red) and signiﬁcant H3K4me3 peaks called using the MACS program. The novel Prdm14 isoform in ysE is supported by a H3K4me3 peak in VYS indicating a novel
promoter for this gene. Bottom: DEXSeq differential exon usage analysis shows a signiﬁcant differential isoform expression between E12.5 ysE and cystic EBs.
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ference may or may not affect the protein sequence and molecular
function of this important endoderm transcription factor, indi-
cating that it is regulated differently and may thus also explain the
signiﬁcant difference in expression level between the tissues.
PRDM14 is a transcription factor involved in early development
and pluripotency that is expressed in primordial germ cells, the
inner cell mass and ES cells and has been linked to the regulation
of their unusual epigenetic state by DNA demethylation via the
TET pathway (Okashita et al., 2014). Additionally, it has been
shown to block mouse ES cells from differentiating down the
extra-embryonic endoderm lineage in vitro (Salomonis et al.,
2010). Prdm14 was expressed in cystic EBs consistent with the role
of PRDM14 as a suppressor of extra-embryonic endoderm differ-
entiation, and our results indicating that cystic EBs contain
embryonic, and not extra-embryonic endoderm, although we
cannot exclude that at least part of this expression comes from
remnant undifferentiated cells as indicated by expression of other
pluripotency markers in cystic EBs (Fig. S1G). However, we were
surprised whenwe also detected robust Prdm14 expression in both
E9.25 and E12.5 ysE. De novo assembly and differential exon usage
analysis showed that while cystic EBs expressed the canonical
form of Prdm14, an alternative promoter was used in ysE to
express an isoform that included only the last four 3' exons. An
H3K4me3 ChIP-seq peak from E12.5 VYS overlapped the 5' end of
the predicted transcript conﬁrming use of an alternative promoter
(Fig. 5D). Possible translational start sites for all 3 open reading
frames are present at the start or slightly upstream of the detected
expression including a putative 200 amino-acid sequence in
frame with the known PRDM14 isoform. However, the ysE speciﬁc
isoform would lack the N terminal and a part of the PR domain
essential for the interactions with TET proteins (Okashita et al.,
2014) indicating that if this isoform is biologically active its mode
of action will differ from the canonical isoform. In summary, the
large number of differentially expressed genes between ysE and
cystic EBs are enriched for regulators of transcription, plus differ-
ential isoform usage between the tissues including important
regulators of endoderm identity, indicating that cystic EBs have a
regulatory network distinct from ysE.Discussion
The regulation of imprinted expression in extra-embryonic
lineages appears to differ from embryonic lineages, but investi-
gation of the mechanism is limited by the lack of a validated in
vitro cell differentiation system that mimics the development of
EXEL tissues. The differentiation of mouse ES cells into cystic EBs
has been reported to form structures analogous to the VYS of a
mid-gestation embryo that includes the ysE extra-embryonic
lineage. Therefore, we investigated if cystic EBs could be used to
model EXEL speciﬁc imprinted expression as seen in ysE (Hudson
et al., 2011). We developed a protocol that allowed efﬁcient dif-
ferentiation of ES cells into cystic EBs that reproduced the reported
morphology and marker expression. However, we report here that
cystic EBs do not show EXEL speciﬁc imprinted expression but
instead resemble embryonic lineages in their imprinted expres-
sion pattern. Furthermore, our WGBS DNA methylation and tran-
scriptome analysis indicates that cystic EBs contain embryonic
deﬁnitive endoderm rather than ysE, explaining the observed
imprinted expression pattern.
Cystic EBs provide a reliable model of ML imprinted expression
Differentiation of ES cells into different lineages provides
valuable in vitro models of development that are amenable toexperimental manipulation, enabling more rapid and cost effective
testing of hypotheses than in animal models. Previously, ES dif-
ferentiation into monolayers, standard EBs (hanging drop culture)
and the neuronal lineage have been reported to recapitulate the
developmental dynamics of imprinted expression for individual
ML imprinted genes (Kohama et al., 2012; Latos et al., 2009; Meng
et al., 2012; Wood et al., 2010). Here all tested ML genes showed
imprinted expression in cystic EBs, demonstrating that differ-
entiation into cystic EBs provides a robust model of ML imprinted
expression that can be used in future studies.
Cystic EBs show an embryonic rather than an extra-embryonic epi-
genetic state
Cystic EBs have been reported to contain a cell layer resembling
the extra-embryonic ysE (Abe et al., 1996; Doetschman et al., 1985;
Kurosawa, 2007; Yasuda et al., 2009). Therefore, it was expected
that cystic EBs would show an epigenetic state similar to that seen
in the extra-embryonic ysE. However, we found that cystic EBs do
not show EXEL-speciﬁc imprinted expression, an epigenetic hall-
mark of extra-embryonic lineages (Hudson et al., 2011). Moreover,
cystic EBs showed a relatively high level of DNA methylation, both
globally and on speciﬁc genic and repeat elements, that was
similar to embryonic liver, and distinct from extra-embryonic ysE,
which showed relatively low DNA methylation levels. This shows
that ysE is globally hypomethylated as shown for the extra-
embryonic placenta (Popp et al., 2010). Related to this, in com-
parison to embryonic tissues and cystic EBs, the ysE showed high
expression of IAPEz repeats as seen in placenta, and high expres-
sion of the genome defense gene Tex19.1 that is known to suppress
expression of LINEs expression in placenta where they are lowly
methylated (Reichmann et al., 2013). Thus our data indicate that,
contrary to expectation, cystic EBs have an embryonic-like rather
than extra-embryonic epigenetic state. Although mouse ES cells
are derived from E3.5 embryos prior to the differentiation of the
primitive endoderm, they have been suggested to resemble a later
stage of epiblast development where differentiation down the
primitive endoderm lineage leading to the ysE may no longer be
possible. In agreement with this ES cells injected into a blastocyst
or morula contributed to the extra-embryonic lineages at a very
low frequency (Beddington and Robertson, 1989) or did not con-
tribute at all (Lallemand and Brulet, 1990). Contribution of ES cells
to the extra-embryonic lineages may be improved by culturing in
2i media plus LIF and then selecting cells positive for the extra-
embryonic endoderm marker Hhex for injection into blastocysts,
although contribution to ysE was still extremely low (Morgani
et al., 2013). Early embryos also show imprinted X-inactivation
that is retained in extra-embryonic lineages, but lost in the epi-
blast that undergoes random X-inactivation. Consistent with an
epiblast identity, female ES cells undergo random X-inactivation
upon differentiation (Murakami et al., 2011). This has been con-
ﬁrmed in the endoderm layer of cystic EBs, showing that cystic EBs
lack this epigenetic hallmark of extra-embryonic tissues (Sado
et al., 1996). These reports together with our results indicate that
cystic EBs have an embryonic epigenetic phenotype.
Cystic EBs contain deﬁnitive endoderm rather than yolk sac
endoderm
Cystic EBs have a VYS-like bilaminar morphology and were
thought to contain ysE typical of E10–E13.5 (Abe et al., 1996;
Doetschman et al., 1985), but our analysis of their epigenetic state
indicates that they represent an embryonic tissue type. Gene
ontology analysis, the large number of differentially expressed
genes and differentially used splice variants conﬁrmed that cystic
EBs are a tissue distinct tissue from ysE. We showed by hierarchical
T.M. Kulinski et al. / Developmental Biology 402 (2015) 291–305 303clustering of both DNA methylation and gene expression patterns
that cystic EBs cluster closer to the deﬁnitive endoderm tissue
embryonic liver than the ysE. As a mixed tissue that contains other
cell types in addition to endoderm, it was not expected that cystic
EBs would be identical to either embryonic liver or ysE, but these
global analyses do indicate the type of endoderm that they contain.
The lack of Sfmbt2 imprinted expression, which only shows
imprinted expression in both embryonic and extra-embryonic
lineages prior to E7.5, indicates that cystic EBs represent a later
developmental stage. Most reported endoderm marker genes are
expressed in more than one type of endoderm during development
making it difﬁcult to precisely classify the developmental stage of
the endoderm contained in cystic EBs. However, cystic EBs do show
expression of deﬁnitive endoderm markers such as Lefty1 and Pyy,
while the expression of Cer1 and Hesx1 and faint expression of Otx1
indicates similarity with the developing foregut endoderm (Zorn
and Wells, 2009). This is consistent with the formation of con-
tracting cardiomyocytes in cystic EBs, which in vivo are induced by
foregut endoderm and begin their pulsating action post E8.25,
indirectly indicating the identity of the endoderm present in cystic
EBs (Pal and Khanna, 2005; Zorn and Wells, 2009). These data all
indicate that cystic EBs contain endoderm similar to embryonic
endoderm around E8.5.Conclusions
Here we use analysis of imprinted expression, together with
methylome and transcriptome analysis to show that extra-
embryonic yolk sac endoderm (ysE) has an epigenetic state similar
to that reported for extra-embryonic placenta. In contrast cystic
EBs previously reported to contain ysE, display an embryonic
epigenetic state and contain embryonic rather than extra-
embryonic endoderm, thus they cannot be used as a model of
extra-embryonic tissues as previously suggested (Abe et al., 1996;
Doetschman et al., 1985; Kurosawa, 2007; Yasuda et al., 2009).
However as we show here, EBs do offer a robust in vitro model for
the analysis of ML imprinted expression, adding to previous
reports that EB differentiation can model important develop-
mental processes including cardiomyocyte development and
haematopoiesis (Dang et al., 2002; Doetschman et al., 1985; Pal
and Khanna, 2005). While our results do not exclude that EB dif-
ferentiation may be directed down the primitive endoderm line-
age leading to ysE, for example by overexpression of GATA factors
(Fujikura et al., 2002), our RNAseq expression data shows that
cystic EBs highly express factors associated with visceral endo-
derm speciﬁcation such as Gata4, Gata6, Bmp4 and Hhex (Artus
et al., 2012; Fujikura et al., 2002; Morgani et al., 2013). Thus, either
these factors are insufﬁcient under the conditions used here or
cystic EBs may expresses genes that are antagonistic to ysE
development. The genomic data presented here from two devel-
opmental stages of ysE, which in contrast to placenta studies
contains a homogenous EXEL cell population, together with fetal
liver and cystic EBs, a widely used developmental model, provides
a valuable resource to the epigenetic and developmental com-
munity for further investigations.Acknowledgments
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